+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Cadila Healthcare Ltd
  • Cipla Ltd
  • Divi's Laboratories Ltd
  • Hikal Ltd
  • Lupin Ltd
  • Mylan NV
  • MORE
Aurobindo Pharma Ltd (AUROPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Critical Information Included
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Aurobindo Pharma Ltd (Aurobindo) is a vertically integrated pharmaceutical company that manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs). Its product portfolio is spread across major therapeutic and product categories including antibiotics, anti-retroviral, systemic gastroenterological, central nervous system (CNS), cardiovascular, anti-allergies, anti-diabetics, other therapeutic areas. The company also produces novel proprietary biocatalysts, dietary supplements and fermentation based semi synthetic products. Aurobindo operates manufacturing facilities in India, the US, Brazil and Portugal; and R&D facilities in India and the US. The company exports products to several countries worldwide. Aurobindo is headquartered in Hyderabad, Telangana, India.

Aurobindo Pharma Ltd Key Recent Developments

Jan 11, 2019: Aurobindo Pharma to launch 147 drugs in different therapeutic segments in next 3 years
Dec 21, 2018: Aurobindo Pharma to launch potassium chloride pills in US
Dec 18, 2018: Suntuity delivers one of New Jersey's largest rooftop solar PV systems at Aurobindo Pharmaceuticals
Dec 02, 2018: Aurobindo Pharma Expects First Biosimilar Approval In U.S. In 12-18 Months

Key Benefits

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cadila Healthcare Ltd
  • Cipla Ltd
  • Divi's Laboratories Ltd
  • Hikal Ltd
  • Lupin Ltd
  • Mylan NV
  • MORE
Section 1 - About the Company
  • Aurobindo Pharma Ltd - Key Facts
  • Aurobindo Pharma Ltd - Key Employees
  • Aurobindo Pharma Ltd - Key Employee Biographies
  • Aurobindo Pharma Ltd - Major Products and Services
  • Aurobindo Pharma Ltd - History
  • Aurobindo Pharma Ltd - Company Statement
  • Aurobindo Pharma Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 – Company Analysis
  • Company Overview
  • Aurobindo Pharma Ltd - Business Description
  • Business Segment: API Segment
  • Overview
  • Performance
  • Business Segment: ARV Formulations
  • Overview
  • Performance
  • Business Segment: EU Formulations
  • Overview
  • Performance
  • Business Segment: Growth Markets Formulations
  • Overview
  • Performance
  • Business Segment: US Formulations
  • Overview
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: India
  • Performance
  • Geographical Segment: Rest of the world
  • Performance
  • Geographical Segment: USA
  • Performance
  • R&D Overview
  • Aurobindo Pharma Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Aurobindo Pharma Ltd - Strengths
  • Aurobindo Pharma Ltd - Weaknesses
  • Aurobindo Pharma Ltd - Opportunities
  • Aurobindo Pharma Ltd - Threats
  • Aurobindo Pharma Ltd - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Aurobindo Pharma Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Oct 15, 2018: EU authorities take further action in ongoing review of sartans: Zheijiang Huahai placed under increased supervision; Aurobindo Pharma stopped from supplying irbesartan to the EU Share
  • Jul 17, 2018: Aurobindo to buy Apotex’s businesses in five European countries
  • May 28, 2018: Aurobindo Pharma Q4 FY17-18 and FY17-18 Financial Results
  • Mar 05, 2018: Aurobindo Pharma Issued Clarification on US FDA Observations
  • Mar 05, 2018: Aurobindo Announces Inspection of Unit 4 by US FDA
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Disclaimer
List of Tables
  • Aurobindo Pharma Ltd, Key Facts
  • Aurobindo Pharma Ltd, Key Employees
  • Aurobindo Pharma Ltd, Key Employee Biographies
  • Aurobindo Pharma Ltd, Major Products and Services
  • Aurobindo Pharma Ltd, History
  • Aurobindo Pharma Ltd, Other Locations
  • Aurobindo Pharma Ltd, Subsidiaries
  • Aurobindo Pharma Ltd, Joint Venture
  • Aurobindo Pharma Ltd, Key Competitors
  • Aurobindo Pharma Ltd, Ratios based on current share price
  • Aurobindo Pharma Ltd, Annual Ratios
  • Aurobindo Pharma Ltd, Interim Ratios
  • Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Aurobindo Pharma Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Aurobindo Pharma Ltd, Performance Chart (2014 - 2018)
  • Aurobindo Pharma Ltd, Ratio Charts
  • Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Torrent Pharmaceuticals Ltd
  • Sun Pharmaceutical Industries Ltd
  • Mylan NV
  • Lupin Ltd
  • Hikal Ltd
  • Emcure Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories Ltd
  • Divi's Laboratories Ltd
  • Cipla Ltd
  • Cadila Healthcare Ltd
Note: Product cover images may vary from those shown
Adroll
adroll